Skip to main content

You are here

Marie‐Claire Rowlinson, Ph.D., D(ABMM)

Marie‐Claire Rowlinson, Ph.D., D(ABMM)

Laboratory Chief of Bacterial Disease
University of Nottingham (Ph.D.)
University of California, Los Angeles (ASM CPEP Fellowship)

Research Interests

Prior to joining Wadsworth Center’s Bacterial Diseases Laboratory, Dr. Rowlinson was the Assistant Laboratory Director and CLIA Laboratory Director at the Florida Department of Health, Bureau of Public Health Laboratories in Jacksonville for more than 9 years. In this position she worked to enhance the test menu, implementing many new molecular techniques including next generation sequencing for both clinical diagnostics and surveillance. Prior to that, she worked for 4 years with the Association of Public Health Laboratories (APHL) in their Global Health program, building laboratory capacity in countries around the globe.

Dr. Rowlinson has published more than 25 manuscripts with 8 in 5 years and several book chapters focused on public health infectious disease testing including TB, nontuberculous mycobacteria, and agents of bioterrorism. Over the last year and a half, Dr. Rowlinson worked tirelessly with the team in Florida overseeing SARS‐CoV‐2 testing, bringing on several commercial test systems and providing nearly over 500,000 molecular tests to Florida residents since the beginning of the pandemic.

Dr. Rowlinson is the Chair of the APHL Infectious Diseases Committee and a member of the APHL TB Subcommittee. She also continues to work with APHL on an international level, consulting with the Global Health program, most recently working with the Ukraine Ministry of Health on development of their HIV testing algorithm, including genotyping by sequencing methods. Dr. Rowlinson is currently the ASM Division Y (Public Health) Chair and is a member of the College of American Pathologists (CAP) Microbiology Committee. She held an Adjunct Assistant Professor position in the Division of Infectious Diseases and Global Medicine at the University of Florida in Gainesville working closely with the Southeastern National TB Center, a CDC TB Center of Excellence.


Select Publications

Haley C, Rowlinson MC, Ashkin D.
Tuberculosis Therapy: "In Pursuit of Perfection".
Clin Infect Dis.
DOI: 10.1093/cid/ciaa1573
Peaper DR, Rhoads DD, Sullivan KV, Couturier MR, Humphries RM, Martin IW, Nolte FS, Rowlinson MC, She RC, Simner PJ, Theel ES, Wojewoda CM.
Considerations from the College of American Pathologists for Implementation of an Assay for SARS-CoV-2 Testing after a Change in Regulatory Status.
J Clin Microbiol.
DOI: 10.1128/JCM.01167-21
Papp JR, Rowlinson MC, O'Connor NP, Wholehan J, Razeq JH, Glennen A, Ware D, Iwen PC, Lee LV, Hagan C.
Accuracy and reproducibility of the Etest to detect drug-resistant Neisseria gonorrhoeae to contemporary treatment.
J Med Microbiol.
DOI: 10.1099/jmm.0.000651
Forbes BA, Hall GS, Miller MB, Novak SM, Rowlinson MC, Salfinger M, Somoskövi A, Warshauer DM, Wilson ML.
Practical Guidance for Clinical Microbiology Laboratories: Mycobacteria.
Clin Microbiol Rev.
DOI: 10.1128/CMR.00038-17
Craft DW, Lee PA, Rowlinson MC.
Bioterrorism: a laboratory who does it?.
J Clin Microbiol.
DOI: 10.1128/JCM.00359-14